During the past decade, Meridien Research, Brooksville conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 2 clinical trials were completed, i.e. on average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 1 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Meridien Research, Brooksville" #1 collaborator was "Thrombolysis In Myocardial Infarction (TIMI) Academic Research Organization" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Meridien Research, Brooksville" are "Cardiovascular Disease" (1 trials), "High Cardiovascular Risk" (1 trials), "Obesity" (1 trials), "Overweight" (1 trials) and "Type 2 Diabetes" (1 trials). Many other conditions were trialed in "Meridien Research, Brooksville" in a lesser frequency.

Most popular intervention types in "Meridien Research, Brooksville" are "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (2 trials), "Lorcaserin hydrochloride" (1 trials), "Met DR" (1 trials) and "Met IR" (1 trials). Other intervention names were less common.

The vast majority of trials in "Meridien Research, Brooksville" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Meridien Research, Brooksville". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Meridien Research, Brooksville, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Meridien Research, Brooksville, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".